Defence Online

Type of document: Contract Notice
Country: United Kingdom
Publication Ref: (2024/S 000-036869/EN)
Nature of contract: Supply contract
Procedure: Not applicable
Type of bid required: Not applicable

Prior information notice without call for competition
Supplies

This notice is for prior information only
Section I: Contracting authority
I.1) Name and addresses
Official name: Procurement and Logistics Service
Postal address: 77 Boucher Crescent
Town: Belfast
Postal code: BT12 6HU
Country: United Kingdom
Email: palsgransha.sourcing@hscni.net
Internet address(es):
Main address:

The contract is awarded by central purchasing body
Additional information can be obtained from:
the above mentioned address
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health

Section II: Object
II.1) Scope of the procurement:
II.1.1) Title: NEXT GENERATION SEQUENCING SOLUTION – PIN
II.1.2) Main CPV code: 33000000
II.1.3) Type of contract: Supplies
II.1.4) Short Description:
This is a Prior Information Notice published by the Business Services Organisation (BSO), Procurement and Logistics Service (PaLS) (the Authority), on behalf of our Client – the Belfast Health and Social Care Trust (BHSCT), to enter into pre-market engagement with interested suppliers, as PaLS are commencing work for the provision of a solution for next generation sequencing for the Regional Molecular Diagnostics Service (RMDS) which includes: Genetics, Haematology, Microbiology and Histocompatibility and Immunogenetics Laboratories based in the BHSCT.
II.1.6) Information about lots:
The contract is divided into lots: no
II.2) Description:
II.2.3) Place of performance
Nuts code:
II.2.4) Description of the procurement
This is a Prior Information Notice published by the Business Services Organisation (BSO), Procurement and Logistics Service (PaLS) (the Authority), on behalf of our Client – the Belfast Health and Social Care Trust (BHSCT), to enter into pre-market engagement with interested suppliers, as PaLS are commencing work for the provision of a solution for next generation sequencing for the Regional Molecular Diagnostics Service (RMDS) which includes: Genetics, Haematology, Microbiology, Histocompatibility and Immunogenetics Laboratories based in the BHSCT.
The RMDS offers services for Germline and Somatic testing to improve diagnosis, treatment options and management of patients with cancer, haematological conditions and rare genetic disorders. The germline service is divided into Constitutional Cytogenetics and Molecular Genetics, and the somatic service consists of a solid tumour and hematological malignancies section.
The objectives of the Product Awareness Sessions are to: –
* Gain initial supplier interest in supply and delivery / provision of the Next Generation Sequence Solution.
* Seek interested parties to complete a site visit to RMDS to view current arrangements and floorplans.
* Gain insight on the market possibilities and potential innovative solutions.
* Establish how market ready suppliers currently are.
* Ascertain how suppliers can assist the HSCNI to ensure Health and Safety Standards are met and to ensure compliance with all relevant and future legislation.
* Understand risks and potential issues relating to supply and delivery of Next Generation Sequence Solution.
* Gain a better understanding of the feasibility of the HSCNI requirements and the most appropriate procurement approach to follow.
II.2.5) Award criteria

II.2.14) Additional information: Site Visits: Interested suppliers are requested to visit the client site and is mandatory to understand the client’s infrastructure at the site. Advance arrangement is necessary. The Client has limited capacity to facilitate site visits; therefore, places will be restricted and it may not be possible to accommodate all interested suppliers. Sessions will be allocated on a first come first served basis. Market Engagement Questionnaire: Any interested suppliers are asked to complete and submit the associated questionnaire.. The Product Awareness Sessions will be an opportunity for suppliers to present to a panel of Next Generation Sequencing professionals. Interested suppliers will be invited to a product awareness session. This session will be scheduled to last approximately 60 minutes per presenting organisation and presenters will be required to:- a) Provide a video demonstration of the physical and practical functioning of the proposed solution. This video should last no more than 10 minutes. b) Provide an oral presentation on their equipment, testing capabilities and software to attendees, including IT connectivity capabilities. c). To be available for responding to questions or clarifications from those in attendance following the presentation, covering all aspects of system operation, connectivity, installation, commissioning, training, and after-sales servicing, including contingency services. The oral presentation will be scheduled to last approximately 30 minutes per presenting organisation, and should cover all aspects of functionality, including testing capabilities, turnaround time, throughput, sample processing, compatibility of sample and media types, consumables, quality management, ICT connectivity, software, aftersales support, and contingency. The participating organisations should be available for questions or clarification from those in attendance following the oral presentation, covering all aspects of system operation, connectivity, installation, commissioning, training, and after-sales servicing, including contingency services. Product awareness sessions are scheduled to take place in person, on Wednesday 15th & Friday 17th January 2025. It is likely that the Client will only be able to facilitate 2 days of supplier engagement sessions; therefore,. places will be limited, and it may not be possible to accommodate all interested suppliers. Sessions will be allocated on a first come first served basis. The venue for the product awareness session will be at Belfast City Hospital. To register interest, interested suppliers must complete the Declaration of interest form in Appendix 2, as detailed in the Declaration of Interest document once requested. Specific appointment times will be communicated to each supplier following this date.. What you need to do now: . a) If not registered on eTendersNI, do so on the website www.eTendersNI.gov.uk Go to the ‘Suppliers new to eTendersNI’ section and follow the registration process. Potential tenderers will be required to register against the relevant CPV codes applicable to them to ensure they receive email alerts regarding specific areas of interest. If already registered. b) Potential tenderers should review their contact details to ensure the information is up to date. Assistance is available from eTendersNI Helpdesk, telephone number: 08002404545.. c) Declare your interest in this Supplier engagement exercise by sending an email to palsgransha.sourcing@hscni.net requesting a Declaration of Interest pack.. d) Complete the Declaration of Interest form Appendix 1. e) Submit your completed Declaration of Interest form Appendix 1 by email to palsgransha.sourcing@hscni.net before the deadline at 15.00 hrs Thursday 28th November 2024.. f) Ensure that you will be available to attend site visits W.C. 9th December 2024. g) Complete the Declaration of Interest form Appendix 2 to participate in Product Awareness Session. h) Submit your completed Declaration of Interest form Appendix 2 to participate in Product Awareness Session before the deadline at 15:00 hrs Thursday 19th December 2024.. i) Complete the Market Engagement Questionnaire form. j) Submit the Market Engagement Questionnaire form by 15:00 on Thursday 19th December 2024.. k) Ensure that you will be available to attend the Supplier product awareness Session(s) on Wednesday 15th January 2025 and Friday 17th January 2025 in Belfast City Hospital and be able to present..

II.3) Estimated date of publication of contract notice:2025-05-01
Section IV: Procedure
IV.1) Description
IV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information

Section VI: Complementary information
VI.2) Information about electronic workflows
VI.5) Date of dispatch of this notice:2024-11-14